All News about Mirum Pharmaceuticals IncVia Business Wire
Via Benzinga
FDA Approves First Treatment For Alagille Syndrome-Associated Cholestatic Pruritus From Mirum Pharma
September 29, 2021
Via Benzinga
Exposures
Product Safety
Mirum Pharmaceuticals to Participate in September Investor Conferences
September 02, 2021
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |